IgAN The IgA Nephropathy Foundation’s mission is to be a patient-centric organization focused on finding a cure for IgA Nephropathy
What is IgA Nephropathy? [Immunoglobulin A (IgA)] Learn Here IgA Nephropathy (IgAN) is an autoimmune disease that attacks the kidneys It affects how blood is filtered in the small blood vessels of the kidneys IgAN occurs when an abnormal protein damages the filtering unit (glomerulus) inside the kidneys It is estimated that 20-40% of the people who have IgAN will develop end-stage kidney disease, which means they will need dialysis or kidney
IgANCare Program | IgA Nephropathy Foundation Find an IgAN Health Specialist For Healthcare Providers The IgA Nephropathy Foundation is a patient-centric 501 (c) (3) charitable organization focused on finding cures for IgA Nephropathy There is an urgent need to raise awareness about IgAN, including how it differs from other chronic kidney conditions, and to help assure more timely diagnoses Nearly half of patients (48%) faced delays
Patient and Provider Perspectives on the Patient Journey in . . . Abstract The clinical presentation and disease course of immunoglobulin A nephropathy (IgAN), the most common primary glomerular disease worldwide, vary considerably from patient to patient, often prolonging and complicating the diagnostic process Additionally, the IgAN treatment landscape is rapidly changing, with ongoing development of numerous new agents targeting the underlying disease
Diagnosed with IgA Nephropathy? What You Need to Know Diagnosed with IgA Nephropathy? What You Need to Know If you or a loved one has been diagnosed with IgA Nephropathy, also called IgAN for short, it’s normal to feel scared or uncertain
Go Global Australia | IgA Nephropathy Foundation Source Transplant challenges — Even after a kidney transplant, IgAN can come back and is a leading cause of graft loss Source As part of The IgAN Foundation’s expansion, the Go Global Network will establish a stronger presence in Australia, fostering new partnerships and resources to support Australian IgAN patients and their families
Go Global Canada | IgA Nephropathy Foundation Go Global Canada In Canada, the incidence of IgAN is 1 6 per 100,000, and approximately 260 Canadians are diagnosed yearly As part of the IgA Nephropathy Foundation’s Go Global initiative, we’ve expanded our advocacy and educational efforts into Canada to address the urgent needs of patients navigating limited treatment options
Tools Resources | IgA Nephropathy Foundation Tools Resources As a part of our patient-centric mission focused on finding a cure for IgA Nephropathy and supporting IgAN Warriors, the resources below are designed to help equip and empower you through every part of your treatment journey
Development of animal models of human IgA nephropathy IgA nephropathy (IgAN) is the most common form of primary glomerulonephritis in the world IgAN is char-acterized by the mesangial accumulation of immune complexes containing IgA1, usually with co-deposits of complement C3 and variable IgG and or IgM